Connect with us
Sanofi will invest €1 billion in a new insulin factory in Beijing, its largest investment in China, citing demand from 140 million diabetic adults. This fourth...
Sanofi's €40M capital boost will scale Thymoglobulin production for kidney transplant rejection and internalize diabetes drug Tzield development, acquired via Provention Bio. The investment enhances reliability,...
Agomab raised $90 million in Series D funding, led by Asabys, Sanofi, and Invus. Funds will advance clinical trials for its lead fibrosis treatments, including Agmb-129...
Sanofi seeks a buyer for its consumer healthcare division, valued at around 20 billion euros, with offers due by mid-July. Interested parties include Advent International, PAI...
Sanofi acquires 4.9% of Novavax shares for $70 million, doubling the latter's valuation to around $1.4 billion. This investment is part of a co-exclusive licensing agreement...
With the transaction, Sanofi will assume and repay Inhibrx's outstanding third-party debt and will finance New Inhibrx with $200 million in cash (€183 million) and retain...
Within the health sector, 20% of investment in R&D came from the ten largest companies by investment, which allocated €53.9 billion, €10 billion more than the...
Paris-based Aqemia will receive upfront and milestone payments under the deal that will be used to deepen R&D. In addition, it plans to double its workforce...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
After a relatively lackluster 2021, Amgen was looking for a second wind. The laboratory was only able to survive last year thanks to its collaboration with...